Hauke Cornils

Hauke Cornils is a seasoned professional in the field of biochemistry and molecular biology, currently serving as Vice President of Early Discovery In Vitro Biology at Evotec since August 2014. In this role, Hauke leads the CRISPR/RNAi platform for Target Identification and Validation while managing various internal and client projects across multiple disease areas. Prior to Evotec, Hauke gained valuable experience as a Post Doctoral Fellow at Dana-Farber Cancer Institute, focusing on genomic instability in cancers, and contributed to large-scale research through collaborations with esteemed institutions such as MIT and the Broad Institute. Hauke completed a PhD at the Friedrich Miescher Institute for Biomedical Research, investigating the molecular functions of the NDR/LATS kinase family. Educational credentials include a Diploma in Biochemistry and Molecular Biology from Friedrich Schiller University Jena and an Abitur from Christian Gymnasium Hermannsburg.